Phillies infielder Freddy Galvis had an abscess removed from his left knee on Wednesday. After the procedure, doctors found a staph infection, but that wasn’t the worst news. CSN Philly’s Jim Salisbury reports that Galvis has come down with Methicillin-resistant Staphylococcus aureus, more commonly known as MRSA. Simply put, Galvis has an antibiotic-resistant infection.
Galvis will be out indefinitely. GM Ruben Amaro wouldn’t offer a timetable for his return.
“Clearly, his timeframe would be much longer if it’s MRSA,” Amaro said before Galvis’ diagnosis. “I’m not really sure what the timetable would be if it’s just a staph infection.
“But right now, we’re more concerned about his overall health than anything else. We’ll find out a little more about it when they do some more studies today. He’s going to stay in the hospital. He’s doing an IV antibiotic and also some oral antibiotics. Hopefully after these next couple days it’s just oral antibiotics. We’ll see.”
The Tampa Bay Buccaneers of the NFL dealt with a MRSA outbreak in October. Locker rooms and clubhouses are particularly prone to MRSA outbreaks.
Galvis has become a favorite of manager Ryne Sandberg amid the Jimmy Rollins controversy. He was all but assured a bench spot on the 25-man roster. His absence means that non-roster invitees such as Reid Brignac and Ronny Cedeno have a very real chance to join the team when they break camp.
The Phillies and Red Sox appear intent on pursuing free agent first baseman Carlos Santana, MLB Network’s Jon Morosi reports. Santana rejected a one-year, $17.4 million qualifying offer from the Indians on Thursday and is expected to draw widespread interest on the market this winter. The Mets, Mariners, Angels and Indians could make a play for the infielder, though no serious offers have been made this early in the offseason.
Santana, 31, is coming off of a seven-year track with the Indians. He batted .259/.363/.455 with 23 home runs and 3.0 fWAR last season, making 2017 the fourth-most valuable year of his career to date. Although he was primarily stationed at first base over the last year, he could step back into a hybrid first base/DH role with the Red Sox, who are hurting for infield depth with Hanley Ramirez still working his way back from shoulder surgery.
As for Santana’s other suitors, the Mariners are far less likely to pursue a deal after trading for Ryon Healy last Wednesday. Neither the Mets nor the Phillies have a DH spot to offer the veteran infielder, and the Phillies’ Rhys Hoskins appears to be blocking the way at first base. Then again, Santana may not find a more enticing offer outside of Cleveland, where Edwin Encarnacion might otherwise be the club’s best option at first base. During the GM meetings, Indians’ GM Mike Chernoff said he “love to have both [Santana and Jay Bruce] back” in 2018, but hasn’t backed up that love with any contract talks just yet.